Ortin Laboratories Limited (ORTINLAB)

19.4

INR
-0.23(-1.17%)
As of December 6, 2024 9:59:00 AM

Ortin Laboratories Limited Share Price Information

24 hour Low and High

Low: 19.23999977
High: 19.42000008

All time High

46.55

Price Change 1h

+₹0.08 +0.41%

Price Change 1d

+₹0.08 +0.41%

Price Change 1w

+₹-0.23 +-1.17%

Ortin Laboratories Limited Market Information

Exchange

NSE

Market Cap

16.56 Cr

About Ortin Laboratories Limited Share

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti-diabetics, anti allergics, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides; and anti-anginal and cardio vascular, and antifungal products. Its formulations also include chemo therapeutics, antacids and anti ulcerants, anti spasmodics, calcium and iron preparations, anti-arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti-retroviral products. In addition, the company offers active pharmaceutical ingredient (API) intermediates, including anti retro viral, anti-diabetics, analgesics and antipyretics, anti-biotics, antifungal, antacids and anti ulcerants, and anti malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company provides services in the areas of process development, process and product characterization, analytical research and development, and assay development; and diagnostic services comprising development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; and operates as a merchant exporter of pharmaceutical finished formulations. The company was formerly known as Ortin Laboratories Limited and changed its name to Ortin Global Limited in June 2024. Ortin Global Limited was incorporated in 1986 and is headquartered in Hyderabad, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

24

CEO

Mr. Sanka Murali Krishna Murthy

Revenue (2023)

%

Country of Origin

India

Key Highlights

    FAQs

    Ortin Laboratories Limited (ORTINLAB)

    19.4

    INR
    -0.23(-1.17%)
    As of December 6, 2024 9:59:00 AM

    Ortin Laboratories Limited Share Price Information

    24 hour Low and High

    Low: 19.23999977
    High: 19.42000008

    All time High

    46.55

    Price Change 1h

    +₹0.08 +0.41%

    Price Change 1d

    +₹0.08 +0.41%

    Price Change 1w

    +₹-0.23 +-1.17%

    Ortin Laboratories Limited Market Information

    Exchange

    NSE

    Market Cap

    16.56 Cr

    About Ortin Laboratories Limited Share

    Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti-diabetics, anti allergics, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides; and anti-anginal and cardio vascular, and antifungal products. Its formulations also include chemo therapeutics, antacids and anti ulcerants, anti spasmodics, calcium and iron preparations, anti-arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti-retroviral products. In addition, the company offers active pharmaceutical ingredient (API) intermediates, including anti retro viral, anti-diabetics, analgesics and antipyretics, anti-biotics, antifungal, antacids and anti ulcerants, and anti malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company provides services in the areas of process development, process and product characterization, analytical research and development, and assay development; and diagnostic services comprising development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; and operates as a merchant exporter of pharmaceutical finished formulations. The company was formerly known as Ortin Laboratories Limited and changed its name to Ortin Global Limited in June 2024. Ortin Global Limited was incorporated in 1986 and is headquartered in Hyderabad, India.

    Sector

    Healthcare

    Drug Manufacturers - Specialty & Generic

    Employees

    about

    24

    CEO

    Mr. Sanka Murali Krishna Murthy

    Revenue (2023)

    %

    Country of Origin

    India

    Key Highlights

      FAQs